primary myelofibrosis (PMF)
Primary myelofibrosis: spectrum of imaging features and disease-related complications
14
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis
6
INTERLEUKIN 1β LEVEL AND C- REACTIVE PROTEIN ROLES IN PRIMARY MYELOFIBROSIS PATIENTS TREATED WITH HYDROXYUREA AND RUXOLITINIB
5
β-Arrestin2 mediates progression of murine primary myelofibrosis
16
Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib
5
Rare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosis
6
Coexistence of primary myelofibrosis and chronic lymphocytic leukemia
5
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis
8
<p>t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma</p>
7
Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing
5
Primary myelofibrosis is not primary anymore since the discovery of MPL515 and CALR mutations as driver causes of mono-linear megakaryocytic and dual megakaryocytic granulocytic myeloproliferation and secondary myelofibrosis
9
Development of a symptom assessment in patients with myelofibrosis: qualitative study findings
16
Successful Control of Acute Myelofibrosis with Lenalidomide
5
Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
5
Efficacy of ALK5 inhibition in myelofibrosis
16
Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor
9
Download Download PDF
12
A Correlative Study on Bone Marrow Angiogenesis with Bone Marrow Fibrosis and Splenomegaly.
119
Clinical Profile of Philadelphia Negative Myeloproliferative Neoplasms in India.
87
Emerging treatment options for myelofibrosis: focus on pacritinib
11